Full text biomedical articles

Aripiprazole versus other atypical antipsychotics for schizophrenia

Priya Khanna, Tao Suo, Katja Komossa, Huaixing Ma, Christine Rummel‐Kluge, Hany G El‐Sayeh, Stefan Leucht, Jun Xia
Cochrane Database Syst Rev. 2014 Jan; 2014(1): CD006569. Published online 2014 Jan 2. doi: 10.1002/14651858.CD006569.pub5


Article   |   PubReader   |   PDF–27M   |   Cite

Aripiprazole, A Drug that Displays Partial Agonism and Functional Selectivity

Erin W. Tuplin, Matthew R. Holahan
Curr Neuropharmacol. 2017 Nov; 15(8): 1192–1207. Published online 2017 Nov. doi: 10.2174/1570159X15666170413115754


Article   |   PubReader   |   PDF–3.8M   |   Cite

Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism

Andrea de Bartolomeis, Carmine Tomasetti, Felice Iasevoli
CNS Drugs. 2015; 29: 773–799. Published online 2015 Sep 7. doi: 10.1007/s40263-015-0278-3


Article   |   PubReader   |   PDF–1.0M   |   Cite

Aripiprazole Lauroxil: Pharmacokinetic Profile of This Long-Acting Injectable Antipsychotic in Persons With Schizophrenia

Marjie L. Hard, Richard J. Mills, Brian M. Sadler, Ryan Z. Turncliff, Leslie Citrome
J Clin Psychopharmacol. 2017 Jun; 37(3): 289–295. Published online 2017 Mar 27. doi: 10.1097/JCP.0000000000000691


Article   |   PubReader   |   PDF–424K   |   Cite

Aripiprazole (intramuscular) for psychosis‐induced aggression or agitation (rapid tranquillisation)

Edoardo G Ostinelli, Salwan Jajawi, Styliani Spyridi, Kamlaj Sayal, Mahesh B Jayaram, Cochrane Schizophrenia Group
Cochrane Database Syst Rev. 2018 Jan; 2018(1): CD008074. Published online 2018 Jan 8. doi: 10.1002/14651858.CD008074.pub2


Article   |   PubReader   |   PDF–857K   |   Cite

Aripiprazole for autism spectrum disorders (ASD)

Lauren E Hirsch, Tamara Pringsheim, Cochrane Developmental, Psychosocial and Learning Problems Group
Cochrane Database Syst Rev. 2016 Jun; 2016(6): CD009043. Published online 2016 Jun 26. doi: 10.1002/14651858.CD009043.pub3


Article   |   PubReader   |   PDF–543K   |   Cite

Population Pharmacokinetic Analysis and Model-Based Simulations of Aripiprazole for a 1-Day Initiation Regimen for the Long-Acting Antipsychotic Aripiprazole Lauroxil

Marjie L. Hard, Angela Y. Wehr, Brian M. Sadler, Richard J. Mills, Lisa von Moltke
Eur J Drug Metab Pharmacokinet. 2018; 43(4): 461–469. Published online 2018 Jun 11. doi: 10.1007/s13318-018-0488-4


Article   |   PubReader   |   PDF–879K   |   Cite

Dopamine receptor D2 activation suppresses the radiosensitizing effect of aripiprazole via activation of AMPK

Hyounji Lee, Seongman Kang, Jong Kyung Sonn, Young‐Bin Lim
FEBS Open Bio. 2019 Sep; 9(9): 1580–1588. Published online 2019 Jul 23. doi: 10.1002/2211-5463.12699


Article   |   PubReader   |   PDF–1.0M   |   Cite

Unbiased screen identifies aripiprazole as a modulator of abundance of the polyglutamine disease protein, ataxin-3

Maria do Carmo Costa, Naila S. Ashraf, Svetlana Fischer, Yemen Yang, Emily Schapka, Gnanada Joshi, Thomas J. McQuade, Rahil M. Dharia, Mark Dulchavsky, Michelle Ouyang, David Cook, Duxin Sun, Martha J. Larsen, Jason E. Gestwicki, Sokol V. Todi, Magdalena I. Ivanova, Henry L. Paulson
Brain. 2016 Nov; 139(11): 2891–2908. Published online 2016 Sep 19. doi: 10.1093/brain/aww228


Article   |   PubReader   |   PDF–2.6M   |   Cite

Aripiprazole Once-Monthly 400 mg: Comparison of Pharmacokinetics, Tolerability, and Safety of Deltoid Versus Gluteal Administration

Arash Raoufinia, Timothy Peters-Strickland, Anna-Greta Nylander, Ross A. Baker, Anna Eramo, Na Jin, Patricia Bricmont, Jennifer Repella, Robert D. McQuade, Peter Hertel, Frank Larsen
Int J Neuropsychopharmacol. 2017 Apr 1; 20(4): 295–304. Published online 2017 Feb 15. doi: 10.1093/ijnp/pyw116


Article   |   PubReader   |   PDF–334K   |   Cite

Unique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3β Signalling Pathways in Rats

Bo Pan, Jiezhong Chen, Jiamei Lian, Xu-Feng Huang, Chao Deng
PLoS One. 2015; 10(7): e0132722. Published online 2015 Jul 10. doi: 10.1371/journal.pone.0132722


Article   |   PubReader   |   PDF–1.5M   |   Cite

Molecular Determinants of the Intrinsic Efficacy of the Antipsychotic Aripiprazole

Carmen Klein Herenbrink, Ravi Verma, Herman D. Lim, Anitha Kopinathan, Alastair Keen, Jeremy Shonberg, Christopher J. Draper-Joyce, Peter J. Scammells, Arthur Christopoulos, Jonathan A. Javitch, Ben Capuano, Lei Shi, J. Robert Lane
ACS Chem Biol. Author manuscript; available in PMC 2020 Jul 16.
Published in final edited form as: ACS Chem Biol. 2019 Aug 16; 14(8): 1780–1792. Published online 2019 Aug 5. doi: 10.1021/acschembio.9b00342


Article   |   PubReader   |   PDF–1.7M   |   Cite

Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled Study

Hironobu Ichikawa, Katsunaka Mikami, Takashi Okada, Yushiro Yamashita, Yuko Ishizaki, Akemi Tomoda, Hiroaki Ono, Chiharu Usuki, Yoshihiro Tadori
Child Psychiatry Hum Dev. 2017; 48(5): 796–806. Published online 2016 Dec 21. doi: 10.1007/s10578-016-0704-x


Article   |   PubReader   |   PDF–750K   |   Cite

Repeated administration of aripiprazole produces a sensitization effect in the suppression of avoidance responding and phencyclidine-induced hyperlocomotion and increases D2 receptor-mediated behavioral function

Jun Gao, Rongyin Qin, Ming Li
J Psychopharmacol. Author manuscript; available in PMC 2016 Feb 17.
Published in final edited form as: J Psychopharmacol. 2015 Apr; 29(4): 390–400. Published online 2015 Jan 13. doi: 10.1177/0269881114565937


Article   |   PubReader   |   PDF–984K   |   Cite

Antipsychotics drug aripiprazole as a lead against breast cancer cell line (MCF-7) in vitro

Adnan Badran, Atia tul-Wahab, Humaira Zafar, Nayab Mohammad, Rehan Imad, Mariam Ashfaq Khan, Elias Baydoun, M. Iqbal Choudhary
PLoS One. 2020; 15(8): e0235676. Published online 2020 Aug 3. doi: 10.1371/journal.pone.0235676


Article   |   PubReader   |   PDF–2.2M   |   Cite

Pharmacokinetic Evaluation of a 1-Day Treatment Initiation Option for Starting Long-Acting Aripiprazole Lauroxil for Schizophrenia

Marjie L. Hard, Angela Y. Wehr, Yangchun Du, Peter J. Weiden, David Walling, Lisa von Moltke
J Clin Psychopharmacol. 2018 Oct; 38(5): 435–441. Published online 2018 Jul 13. doi: 10.1097/JCP.0000000000000921


Article   |   PubReader   |   PDF–678K   |   Cite

Adjunct Aripiprazole Improves Prolactin and Prolactin-Related Side Effects in Premenopausal Women with Psychosis: Results from the DAAMSEL Clinical Trial

Deanna L. Kelly, Megan M. Powell, Heidi J. Wehring, MacKenzie A. Sayer, Ann Marie Kearns, Ann L. Hackman, Robert Buchanan, Rebecca B. Nichols, Heather A. Adams, Charles M. Richardson, Gopal Vyas, Robert P. McMahon, Amber K. Earl, Kelli M. Sullivan, Fang Liu, Sarah Luttrell, Faith B. Dickerson, Stephanie M. Feldman, Supriya Narang, Maju M. Koola, Peter F. Buckley, Jill A. RachBeisel, Joseph P. McEvoy
J Clin Psychopharmacol. Author manuscript; available in PMC 2019 Aug 1.
Published in final edited form as: J Clin Psychopharmacol. 2018 Aug; 38(4): 317–326. doi: 10.1097/JCP.0000000000000898


Article   |   PubReader   |   PDF–146K   |   Cite

Aripiprazole for cocaine abstinence: a randomized controlled trial with ecological momentary assessment

Landhing M. Moran, Karran A. Phillips, William J. Kowalczyk, Udi E. Ghitza, Daniel A. Agage, David H. Epstein, Kenzie L. Preston
Behav Pharmacol. Author manuscript; available in PMC 2018 Feb 1.
Published in final edited form as: Behav Pharmacol. 2017 Feb; 28(1): 63–73. doi: 10.1097/FBP.0000000000000268


Article   |   PubReader   |   PDF–1.6M   |   Cite

Association of Aripiprazole With the Risk for Psychiatric Hospitalization, Self-harm, or Suicide

François Montastruc, Rui Nie, Simone Loo, Soham Rej, Sophie Dell’Aniello, Joëlle Micallef, Samy Suissa, Christel Renoux
JAMA Psychiatry. 2019 Apr; 76(4): 409–417. Published online 2019 Jan 30. doi: 10.1001/jamapsychiatry.2018.4149


Article   |   PubReader   |   Cite

Safety of aripiprazole for tics in children and adolescents: A systematic review and meta-analysis

Chunsong Yang, Qiusha Yi, Lingli Zhang, Hao Cui, Jianping Mao
Medicine (Baltimore) 2019 May; 98(22): e15816. Published online 2019 May 31. doi: 10.1097/MD.0000000000015816


Article   |   PubReader   |   PDF–304K   |   Cite